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Open access under CC BY-NC-ND license. Adolescence is characterized by exploration, experimenta-
tion, anddfrom the viewpoint of adultsdrisk-taking. When
manifest as health-risk behaviors, such risk-taking can have
serious short- and long-term adverse health consequences.
Health-risk behaviors, which include smoking, substance abuse,
aggression, and early sexual activity, also show signiﬁcant clus-
tering and covariation [1,2]. Involvement in behaviors such as
smoking and sexual activity rises rapidly in early adolescence
beginning about age 12 [3,4]. For example, 80% of adult smokers
initiate smoking before age 18 and virtually none after age 25 [4];
similarly, 58% of young people initiate sex before 18, 77% before
age 20, and more than 90% before age 25 [3]. Importantly,
smoking and risky sexual behaviors such as having multiple
partners frequently persist into adulthood. This adolescent
period of behavior initiation is relatively universal across nations
and cultural groups, even if cultural values and pressures shift
the average age of initiation by a year or two [5].Adolescent risk behaviors are the result of a complex
combination of social, genetic, and developmental factors [2,6],
characterized by an underlying propensity for risk taking that
involves high sensation seeking and immature self-regulation
[7]. Given the covariation in adolescent risk-taking, compre-
hensive interventions for young people are recommended. These
interventions target multiple risk behaviors by enhancing resil-
iency, life circumstances, and life skills rather than through
programs that target risk behaviors one at a time [8,9]. It is
important to note that, although health professionals often focus
on the negative consequences of adolescent risk-taking, being
a risk taker may also have positive consequences, particularly
from the viewpoint of evolutionary survival [10]. Witness Bill
Gates and Steve Jobs who, from adolescence onward challenged
the status quo.
From a life course epidemiologic perspective, adolescence is
a critical period in the development of health and disease
processes. Life course epidemiologydstill a relatively young
ﬁelddis concerned with earlier precursors (risk factors) for later
adverse health outcomes, outcomes whose precursors are often
poorly understood initially because they occurred many years
earlier [11,12]. Key concepts in life course epidemiology include
critical periods of vulnerability, latency between exposure and
outcome, and resiliency in the face of adverse exposures. Life
course epidemiology also considers accumulation of risk
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the potential for chains of risk [11].
Figure 1 places adolescence and risk of cancer within the life
course epidemiological perspective of periods of exposure,
latency, and disease outcomes. As the ﬁgure shows, often
considerable time elapses between a carcinogenic exposure and
clinical disease. For example, the latency periods between
starting to smoke and lung cancer or between acquiring an
oncogenic strain of human papillomavirus (HPV) infection and
cancer are measured in years and decades. Exposures may also
have a complex relationship with time (e.g., cumulative or
progressive). They may also be multifactorial, such as the impact
of smoking and socioeconomic status on adult cardiovascular
disease outcomes. Furthermore, although this special issue of the
Journal of Adolescent Health focuses on adolescent behaviors that
increase risk for cancer in adulthood, from a life course
perspective, adolescence is both a period of exposure to health
risk factors for cancer and a period in which health outcomes
from prenatal or early life exposures can manifest as cancer (e.g.,
the impact of in utero exposure to diethylstilbestrol on adeno-
carcinoma of the vagina) [13].
From a life course perspective, there are unique vulnerabil-
ities at speciﬁc developmental periods that have dramatic
importance for later health outcomes [11,12]. Vulnerability is
deﬁned by sensitive periods in which the effect of an exposure is
greatly magniﬁed. Therefore, if life course and developmental
perspectives are combined, adolescence can be seen as a period
of high vulnerability with multiple transformations occurring
simultaneously: biological growth, development in multiple
organ systems (including the brain and reproductive organs),
increased receptivity to social inﬂuences beyond the family, and
initiation of multiple health risk behaviors. Perhaps the most
obvious vulnerabilitydand the one most amenable to public
health interventionsdis the initiation of health risk behaviors.
Notably, adolescents who initiate sexual intercourse and
smoking earlier than their peers also report increased involve-
ment in risk behaviors as young adults [14,15]. Adult women
reporting early initiation of smoking (earlier than their peers)Figure 1. Adolescence and cancer risalso report greater sexual risk-taking and more adverse repro-
ductive health outcomes [15]. Initiation of tobacco use, because
of its addictive qualities, often results in persistent use
throughout adulthood. Moreover, use of certain gateway drugs
(tobacco and alcohol) during adolescence may lead to use of
other drugs such as cocaine or opiates [16]. Recent research shed
light on one potential mechanism that leads adolescents from
smoking to other drug use: nicotine may prime the developing
adolescent brain to later use of cocaine, providing a molecular
basis for the gateway hypothesis and reinforcing the importance
of early adolescent vulnerability [17].
Life course perspectives on health are supported by cohort
and case-control studies that are increasingly speciﬁc about
period of exposure and that connect distant exposures with
contemporary disease outcomes. Distal social factors, for
instance, have complex and multiple implications that emerge
through multiple pathways. Furthermore, life course cohorts are
also affected by historical context and risk factors may operate
differently over time and across societies and social groups, given
differing social values and practices and changing exposures to
technology. Therefore, the interaction between the period and
cohort effects may have important implications for secular
growth trends such as the changing age of girls at menarche.
Given this complexity, when an exposure and vulnerable period
are identiﬁed, further investigations of the risk factors for the
exposure and strategies to prevent exposure within a critical
period are often warranted.
From a public health perceptive, periods of exposure and
vulnerability are critical because theyarewindowsof opportunity
to prevent disease. However, our review of the life course epide-
miology literature suggested that the vulnerability of adolescents
has been relatively unexamined compared with the vulnerabil-
ities in utero and during early childhood. We have perhaps only
scratched the surface in identifyingexposures during adolescence
that are important to cancer and other health outcomes.
This special issue of the Journal of Adolescent Health on
opportunities for cancer prevention during pre-adolescence and
adolescence reviews research on health-risk behaviors (e.g.,k from a life course perspective.
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initiated during the teenage years and that have importance for
adult risk for cancers (e.g., lung, skin, reproductive, oropharyn-
geal). From a life course epidemiology perspective, these articles
examine exposures during critical, and potentially vulnerable,
periods and offer insights for primary prevention.
Dube and colleagues [18] explore the susceptibility of U.S.
middle and high school students to tobacco advertising in
various media. Advertising was associated with young people’s
susceptibility to smoking, even after controlling for two other
well-known inﬂuences on tobacco use: peer and parental
smoking. Regulation of such advertising is an obvious public
health response.
Holman and Watson [19] examine the correlates of inten-
tional tanning among adolescents and preadolescents aged
8e18 years in the United States, given the importance of this
behavior for skin cancer risk. Intentional tanning is correlated
with individual factors (female sex, older age), participation in
other health risk behaviors, social factors (parental and peer
tanning and parental permission to tan), and environmental
factors such as proximity to tanning facilities. This research
suggests the vulnerability of young people to social and envi-
ronmental inﬂuences. On the basis of their review, the authors
suggest regulatory and environmental approaches that may be
effective in preventing skin cancer risk.
The articles by Thomas et al. [20] and Morales-Campos et al.
[21] address barriers to HPV vaccination in populations where
uptake is low and HPV-related cancer rates are more common.
In 2006, to prevent cervical cancer, the Food and Drug
Administration approved the quadrivalent HPV vaccine for
adolescent and young adult women, and the Advisory
Committee on Immunization Practices (ACIP) recommended that
the three-dose series be routinely administered to 11- to 12-year-
old girls with catch-up for young women up to 26 years old. In
2008, the quadrivalent vaccine was also approved for protection
against vulvar and vaginal cancer, and in 2010 it was approved
for protection against male and female anal cancer. In 2009, the
bivalent vaccine was approved for prevention of cervical cancer.
Vaccination against HPV during adolescence prevents cancer;
it is safe and efﬁcacious, and as such, changes the natural history
of HPV-related cancers. However, national surveys suggest that
less than a quarter of female adolescent and young women are
following the ACIP’s recommendations [22e24]. The National
Immunization Survey-Teen estimated that in 201153% of females
aged 13 to 17 had one dose of the HPV vaccine and 35% had the
recommended three doses. Only 9% of adolescent males had
initiated the vaccine series in 2011, following the ACIP guidance
in 2009 that males 9 to 26 years of age could be vaccinated.
Unfortunately, there continue to be signiﬁcant barriers to HPV
vaccine uptake. In fact, because HPV is an STI, asMorales-Campos
et al. found, some parents feel that vaccination against HPV will
alter their child’s life course negatively by condoning sexual risk-
taking. The Thomas et al. and Morales-Campos et al. articles
suggest that it is important for health care providers and health
promotoras to give parents medical information that might
surmount barriers to vaccination. Such information should
include emphasizing the beneﬁts of the HPV vaccine for cancer
prevention, assuring them of the vaccination’s safety, and
noting that there is no evidence of an association between HPV
vaccination and risky sexual behavior [25].
Why are life course perspectives on cancer risk important
for adolescents? From a public health viewpoint, focusing onprecursors is essential for primary prevention. From a scientiﬁc
viewpoint, it is critical to base primary prevention practices on
a speciﬁc understanding of disease processes and vulnerable
periods, particularly when risk factors and outcomes are
separated widely in time. Finally, in an increasingly antiscience
political sphere, it becomes important to communicate scien-
tiﬁc information to the public in simple and understandable
terms. Cancer prevention faces signiﬁcant challenges in
translating scientiﬁc information for the public and dissemi-
nating it to the public. Public health scientists need to build
scientiﬁc communication expertise and to understand the
popular norms and values that challenge the uptake of
research ﬁndings.
Approaches to prevention for cancer that originate during
adolescence should be based on prevention science. The National
Prevention Strategy, whose development was led by the U.S.
Surgeon General, focuses on healthy and safe community envi-
ronments; clinical and community preventive services, including
vaccination; empowering people; and eliminating health
disparities. Two safe and highly effective vaccines are available to
prevent primary infection with HPV, which can lead to cancer;
these vaccines cover the oncogenic HPV strains that result in
most HPV-related cancers of the cervix, penis, anus, and
oropharynx [26]. Thus, efforts to prevent HPV-related cancer in
today’s adolescents have shifted toward addressing parental and
provider acceptance of the HPV vaccine. In addition to parental
and provider education, use of new technologies such as text
messaging may be an important method to increase adherence
to the multiple-dose vaccination schedules.
To reduce tobacco-related cancers and skin cancer, we need
a combination of strategies to empower young people to adopt
healthful behaviors. Individual behavior change for primary
prevention remains a major challenge to reducing adolescents’
health-risk behaviors, although the complexity of behavior
change is better understood today than 25þ years ago as a result
of efforts to prevent HIV infection. Risk reduction approaches,
including increased awareness, health education, and speciﬁc
risk reduction programs show promise, as do programs to
promote young people’s resiliency [27].
However, focusing on changing individual behavior is gener-
ally less successful than focusing on structural change within
community environments. For example, school mandates are
among the most effective approaches to increasing vaccine
uptake. Structural changes that reduce ﬁnancial and health
system barriers to vaccination are also essential. Effective
structural approaches to reduce smoking among young people
include taxing tobacco products, regulating tobacco sales and
advertising, and countering tobacco company advertising.
Although many approaches to cancer prevention during
adolescence are likely to be effective, no single strategy will be
sufﬁcient.
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